+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Animal Sedative Market Size, Share & Trends Analysis Report By Route of Administration, By Animal Type, By Drug Class, By End Use (Hospitals and Specialty Centers), By Application (Surgical, Diagnostic, and Others), By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 134 Pages
  • July 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5988713
The Latin America, Middle East and Africa Animal Sedative Market is projected to witness market growth of 6.8% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Animal Sedative Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $8.28 millions by 2031. The Argentina market is showcasing a CAGR of 7.4% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 5.9% during (2024 - 2031).



Stringent regulatory standards in developed countries ensure the safety, efficacy, and ethical use of pharmaceutical products, including sedatives. Compliance with regulatory requirements is a critical factor influencing the adoption of sedatives, ensuring that veterinary practices adhere to approved protocols for animal care.

Cultural attitudes towards pets and animals play a role in adoption rates. Countries with a strong tradition of pet ownership and care tend to have higher adoption rates of sedatives for companion animals. In contrast, regions where livestock farming is predominant may focus more on sedatives for large animals in agricultural settings.

The large population of livestock in the UAE requires regular veterinary care for health maintenance, reproductive health, and disease prevention. According to the United Arab Emirates Ministry of climate change & environment, the United Arab Emirates has a significant wealth of livestock. The camel population of the nation stands at 450,000, whereas the estimated number of sheep and goat colonies is around 5 million.

Also, new vet clinics and pet beauty salons tripled during the same period. Future demand is strong, and the sector is expected to grow 87% in the next five years. The expansion of pet veterinary clinics in Brazil leads to increased access to veterinary care for companion animals. This includes routine check-ups, vaccinations, surgeries, dental procedures, and diagnostic tests, often requiring sedatives. Therefore, the high population of livestock and the increasing number of vet clinics in the region are driving the market's growth

List of Key Companies Profiled

  • Koninklijke Philips N.V.
  • Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Visiopharm A/S
  • Paige AI, Inc.
  • PathAI, Inc.
  • Aiforia Technologies Plc
  • Indica Labs, Inc.
  • Optrascan, Inc. (Optra Ventures, LLC)
  • MindPeak GmbH

Market Report Segmentation

By Route of Administration
  • Parenteral
  • Oral
By Animal Type
  • Dogs
  • Cats
  • Horses
  • Others
By Drug Class
  • Alpha-2 Adrenergic Receptor Agonists
  • Phenothiazines
  • Benzodiazepines
  • Butyrophenones
  • Others
By End Use
  • Hospitals
  • Specialty Centers
By Application
  • Surgical
  • Diagnostic
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Animal Sedative Market, by Route of Administration
1.4.2 LAMEA Animal Sedative Market, by Animal Type
1.4.3 LAMEA Animal Sedative Market, by Drug Class
1.4.4 LAMEA Animal Sedative Market, by End Use
1.4.5 LAMEA Animal Sedative Market, by Application
1.4.6 LAMEA Animal Sedative Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Animal Sedative Market by Route of Administration
4.1 LAMEA Parenteral Market by Country
4.2 LAMEA Oral Market by Country
Chapter 5. LAMEA Animal Sedative Market by Animal Type
5.1 LAMEA Dogs Market by Country
5.2 LAMEA Cats Market by Country
5.3 LAMEA Horses Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Animal Sedative Market by Drug Class
6.1 LAMEA Alpha-2 Adrenergic Receptor Agonists Market by Country
6.2 LAMEA Phenothiazines Market by Country
6.3 LAMEA Benzodiazepines Market by Country
6.4 LAMEA Butyrophenones Market by Country
6.5 LAMEA Others Market by Country
Chapter 7. LAMEA Animal Sedative Market by End Use
7.1 LAMEA Hospitals Market by Country
7.2 LAMEA Specialty Centers Market by Country
Chapter 8. LAMEA Animal Sedative Market by Application
8.1 LAMEA Surgical Market by Country
8.2 LAMEA Diagnostic Market by Country
8.3 LAMEA Others Market by Country
Chapter 9. LAMEA Animal Sedative Market by Country
9.1 Brazil Animal Sedative Market
9.1.1 Brazil Animal Sedative Market by Route of Administration
9.1.2 Brazil Animal Sedative Market by Animal Type
9.1.3 Brazil Animal Sedative Market by Drug Class
9.1.4 Brazil Animal Sedative Market by End Use
9.1.5 Brazil Animal Sedative Market by Application
9.2 Argentina Animal Sedative Market
9.2.1 Argentina Animal Sedative Market by Route of Administration
9.2.2 Argentina Animal Sedative Market by Animal Type
9.2.3 Argentina Animal Sedative Market by Drug Class
9.2.4 Argentina Animal Sedative Market by End Use
9.2.5 Argentina Animal Sedative Market by Application
9.3 UAE Animal Sedative Market
9.3.1 UAE Animal Sedative Market by Route of Administration
9.3.2 UAE Animal Sedative Market by Animal Type
9.3.3 UAE Animal Sedative Market by Drug Class
9.3.4 UAE Animal Sedative Market by End Use
9.3.5 UAE Animal Sedative Market by Application
9.4 Saudi Arabia Animal Sedative Market
9.4.1 Saudi Arabia Animal Sedative Market by Route of Administration
9.4.2 Saudi Arabia Animal Sedative Market by Animal Type
9.4.3 Saudi Arabia Animal Sedative Market by Drug Class
9.4.4 Saudi Arabia Animal Sedative Market by End Use
9.4.5 Saudi Arabia Animal Sedative Market by Application
9.5 South Africa Animal Sedative Market
9.5.1 South Africa Animal Sedative Market by Route of Administration
9.5.2 South Africa Animal Sedative Market by Animal Type
9.5.3 South Africa Animal Sedative Market by Drug Class
9.5.4 South Africa Animal Sedative Market by End Use
9.5.5 South Africa Animal Sedative Market by Application
9.6 Nigeria Animal Sedative Market
9.6.1 Nigeria Animal Sedative Market by Route of Administration
9.6.2 Nigeria Animal Sedative Market by Animal Type
9.6.3 Nigeria Animal Sedative Market by Drug Class
9.6.4 Nigeria Animal Sedative Market by End Use
9.6.5 Nigeria Animal Sedative Market by Application
9.7 Rest of LAMEA Animal Sedative Market
9.7.1 Rest of LAMEA Animal Sedative Market by Route of Administration
9.7.2 Rest of LAMEA Animal Sedative Market by Animal Type
9.7.3 Rest of LAMEA Animal Sedative Market by Drug Class
9.7.4 Rest of LAMEA Animal Sedative Market by End Use
9.7.5 Rest of LAMEA Animal Sedative Market by Application
Chapter 10. Company Profiles
10.1 Zoetis, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Virbac
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Product Launches and Product Expansions:
10.2.5 SWOT Analysis
10.3 Dechra Pharmaceuticals PLC
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental & Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Merck & Co., Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Bimeda, Inc.
10.5.1 Company Overview
10.5.2 Recent strategies and developments:
10.5.2.1 Product Launches and Product Expansions:
10.5.3 SWOT Analysis
10.6 Ouro Fino Saude Animal Participacoes S.A.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expenses
10.7 vetcare. fi.
10.7.1 Company Overview
10.8 Chanelle Pharma (Exponent)
10.8.1 Company Overview
10.9 Randlab Australia Pty Ltd.
10.9.1 Company Overview
10.10. Troy Laboratories Pty Ltd.
10.10.1 Company Overview

Companies Mentioned

  • Zoetis, Inc.
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Merck & Co., Inc.
  • Bimeda, Inc.
  • Ouro Fino Saude Animal Participacoes S.A.
  • vetcare. fi.
  • Chanelle Pharma (Exponent)
  • Randlab Australia Pty Ltd.
  • Troy Laboratories Pty Ltd.

Methodology

Loading
LOADING...